Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques

Melanie Pecins-Thompson, Nancy A. Brown, Cynthia Bethea

    Research output: Contribution to journalArticle

    162 Citations (Scopus)

    Abstract

    It has been widely hypothesized that the ovarian steroids, estrogen (E) and progesterone (P), act on serotonin neurons to modulate mood and increase prolactin secretion in women. However, information is needed on the molecular consequences of ovarian hormone action in serotonin neurons. This study examined the effect of E and P on the expression of mRNA for the serotonin re-uptake transporter (SERT) in monkeys using in situ hybridization and a 253 bp human SERT cRNA probe. Monkeys (n = 5 animals/group) were ovariectomized and hysterectomized (spayed) and then untreated (control), or treated with E for 28 days (E treated), or treated with E for 28 days and supplemented with P for the last 14 days of the E regimen (E + P treated). Densitometric analysis of autoradiographs with gray-level thresholding was performed at five levels of the dorsal and median raphe. The number of pixels exceeding background in defined areas was obtained (pixel number). The average pixel number for spayed, E- and E + P-treated groups was 22,280 ± 3517, 15,227 ± 1714, and 14,827 ± 2042, respectively, in the combined dorsal and median raphe. In the E- and E + P-treated groups compared to the control group, there was a 32% and 33% decrease in SERT mRNA signal represented by pixel number (ANOVA, P <0.05). Hence, E- and E + P-treated groups were significantly less than the control group, but they were not different from one another. Also, there were significantly fewer SERT mRNA-positive cells in the dorsal raphe of E- and E + P-treated groups (ANOVA, P <0.001). Therefore E, with or without P, reduces SERT mRNA expression. These results suggest that the ability of P to increase prolactin secretion in E-primed monkeys does not involve an action at the level of SERT gene transcription. Hence, the mechanism by which the CNS transduces the action of P on prolactin secretion remains to be elucidated. However, these data suggest that one action of E replacement therapy in postmenopausal women may be to decrease expression of the SERT gene.

    Original languageEnglish (US)
    Pages (from-to)120-129
    Number of pages10
    JournalMolecular Brain Research
    Volume53
    Issue number1-2
    DOIs
    StatePublished - Jan 1998

    Fingerprint

    Macaca mulatta
    Serotonin
    Steroids
    Messenger RNA
    Prolactin
    Haplorhini
    Analysis of Variance
    Neurons
    Complementary RNA
    Control Groups
    Aptitude
    Genes
    In Situ Hybridization
    Progesterone
    Estrogens
    Hormones

    Keywords

    • Dorsal raphe
    • Estrogen
    • Primate
    • Progesterone
    • Serotonin
    • SERT

    ASJC Scopus subject areas

    • Molecular Biology
    • Cellular and Molecular Neuroscience

    Cite this

    Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. / Pecins-Thompson, Melanie; A. Brown, Nancy; Bethea, Cynthia.

    In: Molecular Brain Research, Vol. 53, No. 1-2, 01.1998, p. 120-129.

    Research output: Contribution to journalArticle

    @article{8a6589456a35460581dd435ffc98fb03,
    title = "Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques",
    abstract = "It has been widely hypothesized that the ovarian steroids, estrogen (E) and progesterone (P), act on serotonin neurons to modulate mood and increase prolactin secretion in women. However, information is needed on the molecular consequences of ovarian hormone action in serotonin neurons. This study examined the effect of E and P on the expression of mRNA for the serotonin re-uptake transporter (SERT) in monkeys using in situ hybridization and a 253 bp human SERT cRNA probe. Monkeys (n = 5 animals/group) were ovariectomized and hysterectomized (spayed) and then untreated (control), or treated with E for 28 days (E treated), or treated with E for 28 days and supplemented with P for the last 14 days of the E regimen (E + P treated). Densitometric analysis of autoradiographs with gray-level thresholding was performed at five levels of the dorsal and median raphe. The number of pixels exceeding background in defined areas was obtained (pixel number). The average pixel number for spayed, E- and E + P-treated groups was 22,280 ± 3517, 15,227 ± 1714, and 14,827 ± 2042, respectively, in the combined dorsal and median raphe. In the E- and E + P-treated groups compared to the control group, there was a 32{\%} and 33{\%} decrease in SERT mRNA signal represented by pixel number (ANOVA, P <0.05). Hence, E- and E + P-treated groups were significantly less than the control group, but they were not different from one another. Also, there were significantly fewer SERT mRNA-positive cells in the dorsal raphe of E- and E + P-treated groups (ANOVA, P <0.001). Therefore E, with or without P, reduces SERT mRNA expression. These results suggest that the ability of P to increase prolactin secretion in E-primed monkeys does not involve an action at the level of SERT gene transcription. Hence, the mechanism by which the CNS transduces the action of P on prolactin secretion remains to be elucidated. However, these data suggest that one action of E replacement therapy in postmenopausal women may be to decrease expression of the SERT gene.",
    keywords = "Dorsal raphe, Estrogen, Primate, Progesterone, Serotonin, SERT",
    author = "Melanie Pecins-Thompson and {A. Brown}, Nancy and Cynthia Bethea",
    year = "1998",
    month = "1",
    doi = "10.1016/S0169-328X(97)00286-6",
    language = "English (US)",
    volume = "53",
    pages = "120--129",
    journal = "Brain Research",
    issn = "0006-8993",
    publisher = "Elsevier",
    number = "1-2",

    }

    TY - JOUR

    T1 - Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques

    AU - Pecins-Thompson, Melanie

    AU - A. Brown, Nancy

    AU - Bethea, Cynthia

    PY - 1998/1

    Y1 - 1998/1

    N2 - It has been widely hypothesized that the ovarian steroids, estrogen (E) and progesterone (P), act on serotonin neurons to modulate mood and increase prolactin secretion in women. However, information is needed on the molecular consequences of ovarian hormone action in serotonin neurons. This study examined the effect of E and P on the expression of mRNA for the serotonin re-uptake transporter (SERT) in monkeys using in situ hybridization and a 253 bp human SERT cRNA probe. Monkeys (n = 5 animals/group) were ovariectomized and hysterectomized (spayed) and then untreated (control), or treated with E for 28 days (E treated), or treated with E for 28 days and supplemented with P for the last 14 days of the E regimen (E + P treated). Densitometric analysis of autoradiographs with gray-level thresholding was performed at five levels of the dorsal and median raphe. The number of pixels exceeding background in defined areas was obtained (pixel number). The average pixel number for spayed, E- and E + P-treated groups was 22,280 ± 3517, 15,227 ± 1714, and 14,827 ± 2042, respectively, in the combined dorsal and median raphe. In the E- and E + P-treated groups compared to the control group, there was a 32% and 33% decrease in SERT mRNA signal represented by pixel number (ANOVA, P <0.05). Hence, E- and E + P-treated groups were significantly less than the control group, but they were not different from one another. Also, there were significantly fewer SERT mRNA-positive cells in the dorsal raphe of E- and E + P-treated groups (ANOVA, P <0.001). Therefore E, with or without P, reduces SERT mRNA expression. These results suggest that the ability of P to increase prolactin secretion in E-primed monkeys does not involve an action at the level of SERT gene transcription. Hence, the mechanism by which the CNS transduces the action of P on prolactin secretion remains to be elucidated. However, these data suggest that one action of E replacement therapy in postmenopausal women may be to decrease expression of the SERT gene.

    AB - It has been widely hypothesized that the ovarian steroids, estrogen (E) and progesterone (P), act on serotonin neurons to modulate mood and increase prolactin secretion in women. However, information is needed on the molecular consequences of ovarian hormone action in serotonin neurons. This study examined the effect of E and P on the expression of mRNA for the serotonin re-uptake transporter (SERT) in monkeys using in situ hybridization and a 253 bp human SERT cRNA probe. Monkeys (n = 5 animals/group) were ovariectomized and hysterectomized (spayed) and then untreated (control), or treated with E for 28 days (E treated), or treated with E for 28 days and supplemented with P for the last 14 days of the E regimen (E + P treated). Densitometric analysis of autoradiographs with gray-level thresholding was performed at five levels of the dorsal and median raphe. The number of pixels exceeding background in defined areas was obtained (pixel number). The average pixel number for spayed, E- and E + P-treated groups was 22,280 ± 3517, 15,227 ± 1714, and 14,827 ± 2042, respectively, in the combined dorsal and median raphe. In the E- and E + P-treated groups compared to the control group, there was a 32% and 33% decrease in SERT mRNA signal represented by pixel number (ANOVA, P <0.05). Hence, E- and E + P-treated groups were significantly less than the control group, but they were not different from one another. Also, there were significantly fewer SERT mRNA-positive cells in the dorsal raphe of E- and E + P-treated groups (ANOVA, P <0.001). Therefore E, with or without P, reduces SERT mRNA expression. These results suggest that the ability of P to increase prolactin secretion in E-primed monkeys does not involve an action at the level of SERT gene transcription. Hence, the mechanism by which the CNS transduces the action of P on prolactin secretion remains to be elucidated. However, these data suggest that one action of E replacement therapy in postmenopausal women may be to decrease expression of the SERT gene.

    KW - Dorsal raphe

    KW - Estrogen

    KW - Primate

    KW - Progesterone

    KW - Serotonin

    KW - SERT

    UR - http://www.scopus.com/inward/record.url?scp=0031932036&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0031932036&partnerID=8YFLogxK

    U2 - 10.1016/S0169-328X(97)00286-6

    DO - 10.1016/S0169-328X(97)00286-6

    M3 - Article

    C2 - 9473622

    AN - SCOPUS:0031932036

    VL - 53

    SP - 120

    EP - 129

    JO - Brain Research

    JF - Brain Research

    SN - 0006-8993

    IS - 1-2

    ER -